FDA inspection
Aurobindo Pharma Ltd: FDA inspection ending May 24, 2019
FDA inspection 1090627 · Voluntary Action Indicated (VAI) · Medchal
Key facts
| Inspection ID | 1090627 |
|---|---|
| Firm | Aurobindo Pharma Ltd |
| FEI number | 3004021229 |
| Address | Unit 3, Survey 313 & 314, Bachupally, Medchal-Malkajgiri District |
| City | Medchal |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | May 24, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data